New form of immunotherapy for blood cancer patients

Loading Video…

This browser does not support the Video element.

Blood cancers are the fourth most common form in the U.S. Relapse is common and treatment can be tough. A new form of immunotherapy is showing great promise. Hematologist and oncologist Doctor Joshua Mansour explains how the immune system plays a role in how cancer develops and describes Car T-cell treatment therapy.